活性成分Active Ingredient

重组人Ⅱ型肿瘤坏死因子受体一抗体融合蛋白

在药品知识图谱中有 2 条已注册药品记录。2 registered medicine records in MedicineGraph.
点击右上角 EN 切换为英文界面Switch to English with the EN button above
2
注册药品Registered medicines
1
产品类型Product types
1
剂型Dosage forms
1
生产企业Manufacturers

相关药品Related Medicines

益赛普
上海中信国健药业股份有限公司 | 本品有两种规格：12.5mg/支，活性为1.25×106AU/支；25mg/支，活性为2.50×106AU/支。 | Registration: 国药准字S20050058
益赛普
上海中信国健药业股份有限公司 | 12.5mg/瓶。 | Registration: 国药准字S20050059

数据覆盖说明Data Coverage Note

药品知识图谱目前仅有 2 条与 重组人Ⅱ型肿瘤坏死因子受体一抗体融合蛋白 相关的已注册药品记录。现有数据不足以形成有意义的统计模式。MedicineGraph currently contains only 2 registered medicine record(s) connected to 重组人Ⅱ型肿瘤坏死因子受体一抗体融合蛋白. Available data is insufficient to establish meaningful patterns.

数据局限性Data Limitations

  • 药品知识图谱不提供适应症、用法用量、禁忌症或用药建议。MedicineGraph does not provide indications, dosage, contraindications, or medication advice.
  • 数据来自药品注册数据库，不代表完整目录。Data comes from medicine registration databases. This is not a complete catalog.
关于数据质量About Data Quality
Entity ID: ACTING::重组人Ⅱ型肿瘤坏死因子受体一抗体融合蛋白
Total records: 2
Band: 2-5
Mode: HONEST_MINIMAL_PAGE
Product families: 1
Name resolution: 1/2
Generated: 2026-08-20
Version: Phase 30.7 V3 Adaptive Full Family